Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Read Ino’s inspiring cancer journey and discover how cutting-edge treatments and pediatric clinical trials are providing hope ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

Patients are put under anesthesia, and a rectal probe is placed which enables real-time imaging and treatment. After the machine takes an image of the prostate, the doctors outline the treatment area ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

The Biohacking Suite includes PEMF mats, lymphatic boots, red light panels, and binaural frequency chairs. Room lighting mimics the natural light spectrum, helping reset the body’s internal clock.